Drug intelligence / Profile preview

autologous muscle-derived stem cells + adipose-derived mesenchymal stem cells

Development stage
Unknown
Lead developer
Royan Institute
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intramuscular
01

Overview

This experimental autologous cell therapy, developed by the Royan Institute, consists of a combination of adipose-derived mesenchymal stem cells (AD-MSC) and muscle-derived stem cells (MDSC) for the treatment of facioscapulohumeral muscular dystrophy (FSHD). The AD-MSCs are sourced from the Royan Adipose Tissue Bank, while the MDSCs are isolated from the patient's own biceps femoralis muscle. The treatment is administered via intramuscular injection into affected muscles, such as the biceps, triceps, and trapezoid, with the goal of regenerating damaged muscle tissue and improving muscle function. A Phase I clinical trial (NCT02208713) was conducted to evaluate the safety and feasibility of this dual-cell transplantation approach.

Other names
AD-MSC + MDSCRoyan Institute FSHD cell therapy

Beyond the preview

Go deeper on autologous muscle-derived stem cells + adipose-derived mesenchymal stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous muscle-derived stem cells + adipose-derived mesenchymal stem cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call